pyridoxine has been researched along with Neoplasms in 55 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hand-foot syndrome (HFS) is a common adverse effect of capecitabine treatment." | 9.24 | Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial. ( Chay, WY; Chia, JWK; Choo, SP; Dent, RA; Koh, KX; Koo, WH; Kwok, LL; Lo, SK; Loh, M; Mok, ZY; Ng, RCH; Soong, RCT; Syn, N; Tan, S; Tham, CK; Toh, HC; Wong, NS; Yap, YS, 2017) |
| "Doxylamine-pyridoxine is the first-line agent for the treatment of nausea and vomiting of pregnancy (NVP) according to Canadian guidelines, and this combination is commonly prescribed to pregnant women." | 7.80 | Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy? ( Chin, J; Persaud, N; Walker, M, 2014) |
| "Hand-foot syndrome (HFS) is a common adverse effect of capecitabine treatment." | 5.24 | Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial. ( Chay, WY; Chia, JWK; Choo, SP; Dent, RA; Koh, KX; Koo, WH; Kwok, LL; Lo, SK; Loh, M; Mok, ZY; Ng, RCH; Soong, RCT; Syn, N; Tan, S; Tham, CK; Toh, HC; Wong, NS; Yap, YS, 2017) |
| "Doxylamine-pyridoxine is the first-line agent for the treatment of nausea and vomiting of pregnancy (NVP) according to Canadian guidelines, and this combination is commonly prescribed to pregnant women." | 3.80 | Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy? ( Chin, J; Persaud, N; Walker, M, 2014) |
| "Pyridoxine deficiency and 4'-deoxypyridoxine produce acrodynia in rats and seborrheic dermatitis in man." | 3.67 | Pyridoxine deficiency and antagonism produce increased ground substance viscosity with resulting seborrheic dermatitis and increased tumor resistance. ( Stone, OJ, 1989) |
| "Celecoxib was effective in preventing HFS in patients who received capecitabine (50." | 2.82 | Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials. ( Franco, PIG; Li, RK; Pandy, JGP, 2022) |
| "Subclinical riboflavin deficiency impairs psychomotor function and vitamin B2 requirement may be enhanced during increased physical activity." | 2.40 | Riboflavin metabolism--relevance to human nutrition. ( Lakshmi, AV, 1998) |
| "Diet has been associated with cancer, heart disease, diabetes, stroke and hypertension, arteriosclerosis, and cirrhosis of the liver." | 2.37 | Implications of nutritional status on human biochemistry, physiology, and health. ( Sauberlich, HE, 1984) |
| " No dose-response relationship was evident." | 1.27 | Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): childhood cancer and the consumption of debendox and related drugs in pregnancy. ( Birch, JM; Cartwright, RA; Hartley, AL; Hopton, PA; Johnston, HE; Mann, JR; McKinney, PA; Stiller, CA; Waterhouse, JA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (78.18) | 18.7374 |
| 1990's | 3 (5.45) | 18.2507 |
| 2000's | 3 (5.45) | 29.6817 |
| 2010's | 4 (7.27) | 24.3611 |
| 2020's | 2 (3.64) | 2.80 |
| Authors | Studies |
|---|---|
| Pandy, JGP | 1 |
| Franco, PIG | 1 |
| Li, RK | 1 |
| Charalambous, A | 1 |
| Tsitsi, T | 1 |
| Astras, G | 1 |
| Paikousis, L | 1 |
| Filippou, E | 1 |
| Gay, F | 1 |
| Aguera, K | 1 |
| Sénéchal, K | 1 |
| Tainturier, A | 1 |
| Berlier, W | 1 |
| Maucort-Boulch, D | 1 |
| Honnorat, J | 1 |
| Horand, F | 1 |
| Godfrin, Y | 1 |
| Bourgeaux, V | 1 |
| Yap, YS | 1 |
| Kwok, LL | 1 |
| Syn, N | 1 |
| Chay, WY | 1 |
| Chia, JWK | 1 |
| Tham, CK | 1 |
| Wong, NS | 1 |
| Lo, SK | 1 |
| Dent, RA | 1 |
| Tan, S | 1 |
| Mok, ZY | 1 |
| Koh, KX | 1 |
| Toh, HC | 1 |
| Koo, WH | 1 |
| Loh, M | 1 |
| Ng, RCH | 1 |
| Choo, SP | 1 |
| Soong, RCT | 1 |
| Persaud, N | 1 |
| Chin, J | 1 |
| Walker, M | 1 |
| Lipka, D | 1 |
| Boratyński, J | 1 |
| TATUM, EL | 1 |
| RITCHEY, MG | 1 |
| MILLER, EC | 2 |
| BAUMANN, CA | 1 |
| RUSCH, HP | 1 |
| Yamaguchi, A | 1 |
| Ogino, Y | 1 |
| Iwakoshi, C | 1 |
| Karasawa, K | 1 |
| Ohki, M | 1 |
| TEDESCHI, GG | 1 |
| IWATSURU, R | 1 |
| KAWATA, H | 1 |
| MASUDA, T | 1 |
| IKEDA, T | 1 |
| KAWATA, Y | 1 |
| BERENBAUM, MC | 1 |
| BARTH, G | 1 |
| DRECHSEL, H | 1 |
| GRAEBNER, H | 1 |
| FARRERASVALENTI, P | 1 |
| ROZMAN, C | 1 |
| WOESSNER, S | 1 |
| AKSENOVA, OV | 1 |
| VEENEMA, RJ | 1 |
| FINGERHUT, B | 1 |
| TANNENBAUM, M | 1 |
| MELICOW, MM | 1 |
| USON, AC | 1 |
| PRICE, TD | 1 |
| HOLTZ, P | 1 |
| PALM, D | 1 |
| LEVY, C | 1 |
| LUSSANA, S | 1 |
| ITO, K | 1 |
| NAKAHARA, I | 1 |
| SAKAMOTO, Y | 1 |
| STOERK, HC | 1 |
| SCHAEFER, AE | 1 |
| COPELAND, DH | 1 |
| SALMON, WD | 1 |
| HALE, OM | 1 |
| LOEFER, JB | 1 |
| GELLHORN, A | 1 |
| JONES, LO | 1 |
| PRICE, JM | 1 |
| MILLER, JA | 1 |
| von Moos, R | 1 |
| Thuerlimann, BJ | 1 |
| Aapro, M | 1 |
| Rayson, D | 1 |
| Harrold, K | 1 |
| Sehouli, J | 1 |
| Scotte, F | 1 |
| Lorusso, D | 1 |
| Dummer, R | 1 |
| Lacouture, ME | 1 |
| Lademann, J | 1 |
| Hauschild, A | 1 |
| Pipino, G | 1 |
| Raffaglio, E | 1 |
| Dickerson, JW | 1 |
| Sauberlich, HE | 1 |
| Miyamoto, H | 1 |
| Kokiya, T | 1 |
| Kosuda, S | 1 |
| Hashimoto, S | 1 |
| Yasu, T | 1 |
| Katayama, M | 1 |
| Suzuki, S | 1 |
| Yoshioka, T | 1 |
| Masaki, E | 1 |
| Kinoshita, F | 1 |
| Maekawa, A | 1 |
| Izumi, K | 1 |
| Takada, I | 1 |
| Tanaka, Y | 1 |
| Ladner, HA | 2 |
| Mitchell, JS | 1 |
| King, EA | 1 |
| Weisselberg, R | 1 |
| Tryfiates, GP | 1 |
| Gannett, PM | 1 |
| Bishop, RE | 1 |
| Shastri, PK | 1 |
| Ammons, JR | 1 |
| Arbogast, JG | 1 |
| Lakshmi, AV | 1 |
| Mason, RP | 1 |
| Poirier, LA | 1 |
| Wise, CK | 1 |
| Delongchamp, RR | 1 |
| Sinha, R | 1 |
| Korzon, M | 1 |
| Korzon, T | 1 |
| Stone, OJ | 1 |
| Chuvykin, MB | 1 |
| Fortmeyer, HP | 1 |
| Salkeld, RM | 1 |
| Merrill, AH | 1 |
| Henderson, JM | 1 |
| Reynolds, RD | 1 |
| McKinney, PA | 1 |
| Cartwright, RA | 1 |
| Stiller, CA | 1 |
| Hopton, PA | 1 |
| Mann, JR | 1 |
| Birch, JM | 1 |
| Hartley, AL | 1 |
| Waterhouse, JA | 1 |
| Johnston, HE | 1 |
| Warburg, O | 1 |
| Geissler, AW | 1 |
| Lorenz, S | 1 |
| Khristov, I | 1 |
| Donchev, T | 1 |
| Karlin, R | 1 |
| Croizat, P | 1 |
| Revol, L | 1 |
| Pommatau, E | 1 |
| Viala, JJ | 1 |
| Dumont, M | 1 |
| Raushenbakh, MO | 1 |
| Kärcher, KH | 1 |
| Holt, JA | 1 |
| Coon, WW | 1 |
| Nagler, E | 1 |
| Mocchi, N | 1 |
| Pollini, F | 1 |
| Nichol, CA | 1 |
| Gailani, SD | 1 |
| Holland, JF | 1 |
| Nussbaum, A | 1 |
| Olson, KB | 1 |
| Sicher, K | 1 |
| Backhouse, TW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double Blind Placebo Control Randomised Trial to Test the Effectiveness of Vitamin B6 in Hand Foot Syndrome[NCT02625415] | 54 participants (Actual) | Interventional | 2016-07-31 | Completed | |||
| Randomized Double-Blind Placebo-Controlled Trial of Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome (HFS)[NCT00486213] | Phase 3 | 210 participants (Actual) | Interventional | 2007-06-30 | Terminated (stopped due to Slow accrual) | ||
| Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine: A Randomized Controlled Trial.[NCT05641246] | Phase 2 | 66 participants (Anticipated) | Interventional | 2022-12-08 | Active, not recruiting | ||
| Prevalence and Burden of Nausea and Vomiting in Pregnant Women in Switzerland: Survey Purity 2022[NCT06055192] | 200 participants (Anticipated) | Observational | 2023-09-30 | Not yet recruiting | |||
| Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone[NCT03028012] | Phase 4 | 10 participants (Actual) | Interventional | 2017-05-02 | Terminated (stopped due to Poor enrollment.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Participants in this study underwent TPIs by the following method. The needle was inserted into the trigger point with the goal of eliciting a local twitch responses(LTRs). When a LTR was obtained, 0.1mL of randomized drug was injected into that location within the muscle. This was repeated until LTRs disappeared, or 1.0mL had been injected, whichever came first. This was performed in a similar manner for all affected muscles, up to a maximum of 2mL. Participants self-report their brief pain inventory at each of their injections (up to four subsequent injections) based off of the standardized Numeric Rating pain Scale (NRS). The NRS is nationally recognized numeric scale from zero to ten, with zero being an example of no pain, one to three would demonstrate mild pain, four to six would be moderate pain, seven to nine would be severe pain and a ten would be the worst pain possible. Improvement in BPI was determined if their NRS score went down with each injection(s). (NCT03028012)
Timeframe: Pre-Post Injections Up to Three Months
| Intervention | Participants (Count of Participants) |
|---|---|
| Ketorolac | 1 |
| Lidocaine | 0 |
| Dexamethasone | 0 |
The BPI was evaluated on a scale from 0-10. Zero would mean no interference and 10 would be calculated at complete interferences. We used a 7-point questionnaire about pain. All scores were calculated at baseline and three months. (NCT03028012)
Timeframe: Baseline and Three Months
| Intervention | score on a scale (Number) | |||
|---|---|---|---|---|
| Participant Number #3 at Baseline | Participant Number #3 at 3 Months | Participant Number #8 at Baseline | Participant #8 at 3 Months | |
| Ketorolac | 8 | 3 | 5 | 3 |
TPI were treated with a needle inserted into the trigger point with the goal of eliciting a local twitch responses(LTRs). When a LTR was obtained, 0.1mL of randomized drug was injected into that location within the muscle. This was repeated until LTRs disappeared, or 1.0mL had been injected, whichever came first. Such was performed in a similar manner for all affected muscles, up to a maximum of 2mL. Participants self-report their brief pain inventory at each of their injections (up to four subsequent injections) based off of the standardized Numeric Rating pain Scale (NRS). The NRS is nationally recognized numeric scale from zero to ten, with zero being an example of no pain,one to three would demonstrate mild pain, four to six would be moderate pain, seven to nine would be severe pain and a ten would be the worst pain possible. Improvement in BPI was determined if their NRS score went down with each injection(s). (NCT03028012)
Timeframe: Pre-Injection and Three Month Post Injection(s)
| Intervention | score on a scale (Number) | |||
|---|---|---|---|---|
| Participant Number 3 at Baseline | Participant Number 3 at 3 Months | Participant Number 8 at Baseline | Participant Number 8 at 3 Months | |
| Ketorolac | 8 | 3 | 5 | 3 |
12 reviews available for pyridoxine and Neoplasms
| Article | Year |
|---|---|
Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials.
Topics: Capecitabine; Celecoxib; Hand-Foot Syndrome; Humans; Neoplasms; Pyridoxine; Randomized Controlled Tr | 2022 |
[Metalloproteinases. Structure and function].
Topics: 4-Aminobenzoic Acid; Animals; Apoptosis; Arthritis; Autoimmune Diseases; Cell Movement; Chloroquine; | 2008 |
PHARMACOLOGICAL ASPECTS OF VITAMIN B6.
Topics: Amino Acids; Antimetabolites; Enzymes; Fatty Acids; Humans; Lipid Metabolism; Metabolism; Neoplasms; | 1964 |
Nutrition of the cancer patient.
Topics: Anorexia; Ascorbic Acid; Cachexia; Drug-Related Side Effects and Adverse Reactions; Enteral Nutritio | 1983 |
Implications of nutritional status on human biochemistry, physiology, and health.
Topics: Alcoholism; Anemia, Hypochromic; Animals; Ascorbic Acid; Avitaminosis; Climate; Dietary Fats; Female | 1984 |
Riboflavin metabolism--relevance to human nutrition.
Topics: Diabetes Mellitus; Female; Humans; Neoplasms; Nutrition Disorders; Pregnancy; Pyridoxine; Respirator | 1998 |
Transmembrane pH gradients in vivo: measurements using fluorinated vitamin B6 derivatives.
Topics: Animals; Fluorescence; Fluorine Radioisotopes; Forecasting; Humans; Hydrogen-Ion Concentration; Magn | 1999 |
[Clinical importance of tryptophan metabolism disorders].
Topics: Amino Acid Metabolism, Inborn Errors; Hartnup Disease; Humans; Neoplasms; Pyridoxine; Tryptophan; Tr | 1978 |
[The role of vitamin B6 in tumor growth].
Topics: Animals; Humans; Neoplasms; Polyamines; Pyridoxine; Tetrahydrofolates; Thymidylate Synthase | 1989 |
Vitamin B6 status in cancer patients: effect of tumor site, irradiation, hormones and chemotherapy.
Topics: Breast Neoplasms; Estrogens; Female; Genital Neoplasms, Female; Humans; Neoplasms; Ovarian Neoplasms | 1988 |
Diseases associated with defects in vitamin B6 metabolism or utilization.
Topics: Alkaline Phosphatase; Arteriosclerosis; Celiac Disease; Female; Hematologic Diseases; Humans; Kidney | 1987 |
[Mechanism of the formation and accumulation of blastomogenic (leukozogenic) metabolites of tryptophan].
Topics: Animals; Carcinogens; Drosophila; Female; Humans; Indican; Indoleacetic Acids; Indoles; Leukemia; Le | 1969 |
3 trials available for pyridoxine and Neoplasms
| Article | Year |
|---|---|
A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD).
Topics: Activities of Daily Living; Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Antim | 2021 |
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ | 2017 |
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ | 2017 |
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ | 2017 |
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ | 2017 |
An assessment of thiethylperazine (Torecan) in the control of radiation-induced nausea and vomiting.
Topics: Antiemetics; Humans; Nausea; Neoplasms; Pyridoxine; Radiotherapy; Thiethylperazine; Vomiting | 1968 |
40 other studies available for pyridoxine and Neoplasms
| Article | Year |
|---|---|
Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6.
Topics: Animals; Antineoplastic Agents; Carbon-Sulfur Lyases; Cell Line, Tumor; Cell Proliferation; Cell Sur | 2017 |
Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?
Topics: Abnormalities, Drug-Induced; Antiemetics; Dicyclomine; Doxylamine; Drug Combinations; Female; Humans | 2014 |
Vitamin content of mouse epidermis during methylcholanthrene carcinogenesis; biotin, choline, inositol, rho-aminobenzoic acid, and pyridoxine.
Topics: 4-Aminobenzoic Acid; Acids; Biotin; Carcinogenesis; Choline; Epidermis; Inositol; Methylcholanthrene | 1946 |
Certain effects of dietery pyridoxine and casein on the carcinogenicity of P-dime-thylaminoazobenzene.
Topics: Azo Compounds; Caseins; Humans; Neoplasms; Pyridoxine | 1945 |
[Trigger point therapy for myofascial pain in cancer patients (second report) analysis results of special use-results surveillance by neovitacain® injection].
Topics: Dibucaine; Humans; Injections; Myofascial Pain Syndromes; Neoplasms; Pyridoxine; Sodium Salicylate; | 2012 |
[Effect of pyridoxine phosphoric esters and of desoxypyridoxine on benzopyrene induced sarcoma in rat].
Topics: Animals; Benzopyrenes; Esters; Neoplasms; Pyridoxine; Rats; Sarcoma; Sarcoma, Experimental; Vitamin | 1952 |
[Studies on the biochemical changes during experimental carcinogenesis. I. The effects of pyridoxine and glutamic acid].
Topics: Carcinogenesis; Glutamates; Glutamic Acid; Neoplasms; Pyridoxine; Vitamin B 6 | 1957 |
A screen for agents inhibiting the immune response and the growth of tumours.
Topics: Alloxan; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antibody Formation; Antineoplastic Agen | 1962 |
[ADDITIONAL DRUG TREATMENT OF TUMOR BEDS. V. ON THE EFFECT OF PYRIDOXINE ON TUMOR GROWTH AND SURVIVAL RATE OF MICE OF THE INBRED NMRI STRAIN IN THE RADIOTHERAPY OF EXPERIMENTAL TUMORS].
Topics: Animals; Animals, Laboratory; Mice; Neoplasms; Neoplasms, Experimental; Pyridoxine; Research; Sarcom | 1963 |
[PRENEOPLASTIC, SIDEROBLASTIC REFRACTORY ANEMIAS].
Topics: Abdominal Neoplasms; Anemia; Anemia, Refractory; Anemia, Sideroblastic; Cecal Neoplasms; Humans; Leu | 1964 |
[DETERMINATION OF VITAMINS OF THE B6 GROUP BY ELECTROPHORESIS ON PAPER].
Topics: Electrophoresis; Humans; Leukemia; Liver Cirrhosis; Neoplasms; Pyridoxine; Vitamin A; Vitamin K; Vit | 1964 |
THE EFFECT OF GONADECTOMY ON THE EXPERIMENTAL PRODUCTION OF BLADDER CARCINOMA IN THE FISCHER RAT (F-FU).
Topics: Animals; Castration; Diet; Fluorenes; Humans; Male; Neoplasms; Neoplasms, Experimental; Orchiectomy; | 1964 |
BLADDER TUMOR INDUCTION IN RATS FED 2-ACETAMIDOFLUORENE (2-AAF) AND A PYRIDOXINE-DEFICIENT DIET.
Topics: 2-Acetylaminofluorene; Carcinogens; Diet; Fluorenes; Liver; Liver Cirrhosis; Liver Cirrhosis, Experi | 1964 |
[PRACTICAL APPLICATIONS OF PYRIDOSCORBINE].
Topics: Alcoholism; Ascorbic Acid; Drug Synergism; Drug Therapy; Fatigue; Geriatrics; Humans; Neoplasms; Pyr | 1964 |
[CLINICAL OBSERVATIONS ON THE SUBJECT OF VITAMIN THERAPY].
Topics: Alcoholism; Drug Therapy; Humans; Kidney Diseases; Liver Cirrhosis; Neoplasms; Pyridoxine; Thiamine; | 1964 |
[STUDIES ON VITAMIN B6 METABOLISM OF CANCER CELLS AND TUMOR-BEARING RAT LIVER. II. UPTAKE OF PYRIDOXINE DERIVATIVES BY TUMOR CELLS AND THE LIVER OF TUMOR-BEARING RATS].
Topics: Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; Permeability; | 1964 |
Growth retardation of lymphosarcoma implants in pyridoxine deficient rats by testosterone and cortisone.
Topics: Androgens; Animals; Cortisone; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Pyridoxine; Rats; Sarcoma | 1950 |
The influence of riboflavin, pyridoxine, inositol, and protein depletion- repletion upon the induction of neoplasms by choline deficiency.
Topics: Choline Deficiency; Folic Acid; Humans; Inositol; Neoplasms; Pyridoxine; Riboflavin; Vitamin B Compl | 1950 |
Effect of pyridoxine and desoxypyridoxine on rat fibrosarcoma grafts.
Topics: Fibrosarcoma; Neoplasms; Pyridoxine; Sarcoma; Vitamin B 6 | 1951 |
Pyridoxine deficient diet and desoxypyridoxine in the therapy of lymphosarcoma and acute leukemia in man.
Topics: Diet; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Neoplasms; Pyridoxine | 1949 |
Intracellular distribution of vitamin B6 in rat and mouse livers and induced rat liver tumors.
Topics: Animals; Cytoplasm; Liver; Mice; Neoplasms; Neoplasms, Experimental; Pyridoxine; Rats; Vitamin B 6 | 1949 |
Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts.
Topics: Adrenal Cortex Hormones; Dermatologic Agents; Doxorubicin; Drug Eruptions; Erythema; Foot Dermatoses | 2008 |
[Treatment of the secondary collateral toxic effects of antiblastic drugs].
Topics: Adrenal Glands; Antineoplastic Agents; Asthenia; Headache; Humans; Hypotension; Nausea; Neoplasms; P | 1967 |
[The effect of Neolamin 3B to the anemia of cancer patients (author's transl)].
Topics: Anemia; Drug Therapy, Combination; Humans; Neoplasms; Pyridoxine; Thiamine; Vitamin B 12; Vitamin B | 1981 |
[Influence of vitamins of the B-group upon cancer patients treated by irradiation: I. Vitamin B6 in local irradiation of tumour rats (author's transl)].
Topics: Animals; Female; Male; Neoplasms; Pyridoxine; Radiation-Protective Agents; Radiotherapy Dosage; Rats | 1980 |
Vitamin B6 and cancer: synthesis and occurrence of adenosine-N6-diethylthioether-N-pyridoximine-5'-phosphate, a circulating human tumor marker.
Topics: Adenosine; Animals; Biomarkers, Tumor; Humans; Hydrogen-Ion Concentration; Neoplasms; Pyridoxine; Ra | 1996 |
Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet.
Topics: Body Mass Index; Diet; Dietary Fats; Erythrocytes; Female; Folic Acid; Homocysteine; Humans; Male; N | 2001 |
Pyridoxine deficiency and antagonism produce increased ground substance viscosity with resulting seborrheic dermatitis and increased tumor resistance.
Topics: Acrodynia; Animals; Dermatitis, Seborrheic; Humans; Inflammation; Models, Biological; Neoplasms; Pyr | 1989 |
Possible consequences of vitamin B6 responsive growth in certain malignant tumors of human origin.
Topics: Humans; Neoplasms; Pyridoxine | 1989 |
Vitamin B6 deficiency and carcinogenesis.
Topics: Animals; Humans; Melanoma; Neoplasms; Neoplasms, Experimental; Pyridoxine; Tryptophan; Vitamin B 6 D | 1986 |
Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): childhood cancer and the consumption of debendox and related drugs in pregnancy.
Topics: Adolescent; Antiemetics; Child; Cyclohexanecarboxylic Acids; Dicyclomine; Dose-Response Relationship | 1985 |
[Genesis of tumor metabolism by vitamin B1 deficiency (thiamine deficiency)].
Topics: Animals; Carbon Dioxide; Chick Embryo; Culture Media; Culture Techniques; NAD; Neoplasms; Oxygen Con | 1970 |
[Treatment of leukopenic and anemic states in patients with malignant neoplasms, treated by chemotherapy and radiation therapy].
Topics: Anemia; Blood Transfusion; Humans; Leukopenia; Neoplasms; Pyridoxine; Vitamin B 12 | 1974 |
[Studies on vitamin B6 deficiency during pregnacy and in various pathological states using pyridoxine saturation test].
Topics: Anemia, Hypochromic; Anemia, Macrocytic; Anemia, Pernicious; Bone Marrow Diseases; Diabetes Mellitus | 1968 |
[Treatment of local and generalized radiation side-effects].
Topics: Aprotinin; Bronchial Neoplasms; Electrolytes; Humans; Intestinal Neoplasms; Neoplasms; Pancreatic Ne | 1969 |
A trial of thiethylperazine ("Torecan") in patients suffering from radiation sickness.
Topics: Dimenhydrinate; Feeding and Eating Disorders; Humans; Nausea; Neoplasms; Pyridoxine; Radiation Injur | 1965 |
The tryptophan load as a test for pyridoxine deficiency in hospitalized patients.
Topics: Adult; Aged; Arteriosclerosis; Female; Gastrointestinal Diseases; Humans; Kynurenine; Male; Middle A | 1969 |
[Clinical trials of the combination: orthoxyquinoline sulfonate of aminophenazone-vitamin B 6- vitamin B 12 (Liocausyth) in rheumatological and neuritic diseases].
Topics: Adult; Aged; Aminopyrine; Analgesics; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Neuri | 1967 |
The manipulation of metabolism by drugs and nutrients.
Topics: Antimetabolites; Asparaginase; Folic Acid Antagonists; Models, Chemical; Neoplasms; Nutritional Phys | 1969 |
Clinical and biochemical studies of pyridoxine deficiency in patients with neoplastic diseases.
Topics: Adult; Aged; Aspartate Aminotransferases; Diet; Female; Humans; Leukocytes; Male; Middle Aged; Neopl | 1968 |